TruBridge (NASDAQ:TBRG) Given New $17.00 Price Target at Stephens

TruBridge (NASDAQ:TBRG) had its price objective boosted by Stephens from $13.00 to $17.00 in a research note published on Wednesday,Benzinga reports. They currently have an equal weight rating on the stock.

Several other research analysts have also weighed in on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $13.00 price objective on shares of TruBridge in a research note on Friday, October 4th. Barclays upped their price target on shares of TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $14.00 price objective on shares of TruBridge in a report on Tuesday, September 17th.

TruBridge Trading Up 0.9 %

Shares of NASDAQ:TBRG opened at $16.52 on Wednesday. The company’s 50-day moving average price is $13.08 and its two-hundred day moving average price is $11.53. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.80 and a quick ratio of 1.78. TruBridge has a one year low of $7.55 and a one year high of $16.62. The stock has a market capitalization of $246.56 million, a PE ratio of -4.04, a price-to-earnings-growth ratio of 7.46 and a beta of 0.61.

Insider Transactions at TruBridge

In related news, major shareholder Pinetree Capital Ltd. purchased 3,997 shares of TruBridge stock in a transaction on Wednesday, October 2nd. The stock was acquired at an average cost of $11.93 per share, for a total transaction of $47,684.21. Following the completion of the acquisition, the insider now owns 603,997 shares of the company’s stock, valued at $7,205,684.21. This trade represents a 0.67 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On TruBridge

A number of large investors have recently bought and sold shares of TBRG. Hotchkis & Wiley Capital Management LLC acquired a new stake in TruBridge in the third quarter worth $5,934,000. CacheTech Inc. acquired a new stake in TruBridge in the third quarter worth $2,875,000. Invenomic Capital Management LP acquired a new stake in TruBridge in the third quarter worth $2,364,000. Geode Capital Management LLC acquired a new stake in TruBridge in the third quarter worth $1,747,000. Finally, Rice Hall James & Associates LLC bought a new position in shares of TruBridge in the third quarter valued at $1,143,000. 88.64% of the stock is currently owned by institutional investors and hedge funds.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.